
Recombinetics
Developer of gene editing technologies designed to improve human health through advanced disease models and regenerative medicine. The company's technologies manipulate deoxyribonucleic acid (DNA) sam...
Valuation
$0
Share Price
N/A
Total Raised
$71.7M
Last Round
N/A